Medtronic's surgical device sales decline due to inventory issues CEO Martha monitors impact of Trump's tariffs Shares down more than 7% in morning trade Feb 18 (Reuters) - Medtronic (MDT.N), opens ...

Its shares have lost a third of their value since mid-2021, lifting the dividend yield up to 3.1%. The company's growth has stalled out, but management is working on the issue. Medtronic is about to ...

Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's spinoff plans, growth strategy and surgical robotics. Got a confidential news tip? We want to hear from you. Sign up for free ...

Medtronic boasts strong free cash flow, stable dividends, and innovation focus, but faces macro headwinds, high debt, and competitive pressures. Recent strategic portfolio moves, including spin-offs ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. However, the company decided to spin off this segment into a stand-alone corporation. Still, Medtronic ...

Medtronic’s stock sat on the discount rack for years. Then, in August, a well-known activist investor finally took the bait, buying a sizeable stake in the nation’s largest medical device company and ...

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, March 5, 2026, approved the company's cash dividend for the fourth quarter of fiscal year 2026 of $0.71 per ordinary share. This ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that Thierry Piéton, Medtronic executive vice president and chief financial officer, will participate in fireside ch ...